New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children’s vaccines, has brought immunisation rates to record highs in poor countries.
The WHO data, released today at the World Economic Forum’s annual meeting, project that since 2000, GAVI-funded immunisation programs in developing countries have prevented approximately 2.3 million future deaths, and that immunisations in 2006 alone prevented 600,000 future deaths.
Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, called the new data a highly encouraging sign of progress in global health. The Gates Foundation has committed a total of US$1.5 billion to support GAVI to date. GAVI has also received funding from 17 donor governments, including Germany, which recently committed €8 million (US$10.4 million).
"GAVI and its partners are leading a major turnaround in children’s health," said Melinda Gates. "When GAVI was founded, immunisation rates in poor countries were on the decline. Today, they are at an all-time high."
Since its inception in 2000, GAVI has committed US$2.6 billion to support national immunisation programs in more than 70 developing countries. According to the WHO projections released today, as a result of GAVI funding:
- 28 million more children have been protected against diphtheria, tetanus, and pertussis, helping to increase overall immunisation rates for these diseases from 63 percent in 1999 to 77 percent in 2006.
- 138 million more children have received new and under-used vaccines, such as those for hepatitis B, Hib, and yellow fever, helping to greatly increase immunisation coverage for these diseases. For example, the number of developing countries providing hepatitis B vaccine rose from 15 in 1999 to 61 in 2006.
"GAVI has demonstrated that with the right resources and leadership, it is possible to make dramatic health gains in poor countries," said Bill Gates. "We need to build on this success. No child should be denied access to lifesaving immunisations."
Despite GAVI’s progress, in 2005, an estimated 28 million children in developing countries were not immunised, and 2.5 million children died of vaccine-preventable diseases. To close this gap, WHO and UNICEF estimate that an additional US$10-15 billion will be needed for immunisation programs over the next decade. More funding will be needed to introduce vaccines that are currently in the development pipeline.
GAVI Commits US$500 Million to Strengthen Health Systems
In an effort to further increase global immunisation coverage, GAVI also announced today that it will invest US$500 million over five years to strengthen basic health systems in developing countries.
Weak health care infrastructure is often the main barrier to providing immunisations to children in developing countries, particularly in the poorest and most remote communities.
The new GAVI funding will provide flexible grants to developing countries for activities such as:
- Recruiting and training health care workers- Building and strengthening systems to distribute vaccines and drugs
"This is an exciting new direction for us," said Julian Lob-Levyt, Executive Secretary of GAVI. "Developing country leaders are telling us that in order for immunisation programs to be sustained, they need greater support for basic health infrastructure."
The first round of GAVI grants for strengthening health systems will be announced in February.
Jean-Pierre Le Calvez | EurekAlert!
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
16.03.2018 | Earth Sciences
16.03.2018 | Physics and Astronomy
16.03.2018 | Life Sciences